Compounds > cyc 202
Page last updated: 2024-09-04

cyc 202 and ((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one)

cyc 202 has been researched along with ((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one) in 2 studies

Compound Research Comparison

Studies
(cyc 202)		Trials
(cyc 202)		Recent Studies (post-2010)
(cyc 202)		Studies
(((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one))		Trials
(((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one))		Recent Studies (post-2010) (((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one))
9797393808

Protein Interaction Comparison

ProteinTaxonomycyc 202 (IC50)((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one) (IC50)
Glycogen synthase kinase-3 beta Sus scrofa (pig)0.58
[Tau protein] kinase Sus scrofa (pig)0.58
Dual specificity protein kinase CLK2Mus musculus (house mouse)0.39
Dual specificity protein kinase CLK3Mus musculus (house mouse)2.1
Dual specificity protein kinase CLK4Mus musculus (house mouse)0.0393
Dual specificity tyrosine-phosphorylation-regulated kinase 3Homo sapiens (human)0.4167
Cytochrome P450 3A4Homo sapiens (human)0.071
Serine/threonine-protein kinase pim-1Homo sapiens (human)2.06
Casein kinase II subunit alpha'Homo sapiens (human)0.415
Cannabinoid receptor 1Homo sapiens (human)0.314
Dual specificity protein kinase CLK1Mus musculus (house mouse)0.036
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.071
Dual specificity protein kinase CLK1Homo sapiens (human)0.071
Glycogen synthase kinase-3 alphaHomo sapiens (human)0.21
Glycogen synthase kinase-3 betaHomo sapiens (human)0.38
Casein kinase II subunit betaHomo sapiens (human)0.415
Casein kinase II subunit alphaHomo sapiens (human)0.415
Cyclin-dependent-like kinase 5 Homo sapiens (human)0.41
Dual specificity tyrosine-phosphorylation-regulated kinase 1AHomo sapiens (human)0.0371
Cyclin-dependent kinase 5 activator 1Homo sapiens (human)0.41
Dual specificity tyrosine-phosphorylation-regulated kinase 1ARattus norvegicus (Norway rat)0.03
Casein kinase II subunit alpha 3Homo sapiens (human)0.51
Dual specificity tyrosine-phosphorylation-regulated kinase 2Homo sapiens (human)0.0855
Dual specificity tyrosine-phosphorylation-regulated kinase 4Homo sapiens (human)0.52
Dual specificity tyrosine-phosphorylation-regulated kinase 1BHomo sapiens (human)0.055

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babault, L; Baratte, B; Bazureau, JP; Carreaux, F; Debdab, M; Eisenreich, A; Fedorov, O; Filippakopoulos, P; Hagiwara, M; Knapp, S; Lozach, O; Meijer, L; Ogawa, Y; Rauch, U; Renault, S; Soundararajan, M; Tahtouh, T1
Bendjeddou, LZ; Galons, H; Loaëc, N; Meijer, L; Oumata, N; Prina, E; Späth, GF; Villiers, B1

Other Studies

2 other study(ies) available for cyc 202 and ((5z)5-(1,3-benzodioxol-5-yl)methylene-2-phenylamino-3,5-dihydro-4h-imidazol-4-one)

ArticleYear
Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.
    Journal of medicinal chemistry, 2011, Jun-23, Volume: 54, Issue:12

    Topics: Alternative Splicing; Animals; Aquatic Organisms; Benzodioxoles; Crystallography, X-Ray; Cyclin-Dependent Kinases; Dyrk Kinases; Endothelial Cells; Humans; Imidazolines; Microvessels; Models, Molecular; Nuclear Proteins; Phosphorylation; Porifera; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Quantitative Structure-Activity Relationship; RNA Precursors; RNA-Binding Proteins; Serine-Arginine Splicing Factors; Stereoisomerism

2011
Exploration of the imidazo[1,2-b]pyridazine scaffold as a protein kinase inhibitor.
    European journal of medicinal chemistry, 2017, Jan-05, Volume: 125

    Topics: Antiparasitic Agents; Cell Survival; Enzyme Activation; Eukaryota; Inhibitory Concentration 50; Molecular Structure; Protein Kinase Inhibitors; Pyridazines

2017